publication date: Jan. 25, 2019

Funding Opportunities

Colorectal Cancer Alliance announces funding recipients for colon and rectal cancer research needs

Colorectal Cancer Alliance is providing a total of $625,000 in grants to four researchers, including one advancing personalized treatment options for rectal cancer patients and three seeking to understand the root cause of rising colorectal cancer rates in patients under age 50.

Grant recipients include:

  • J. Joshua Smith of Memorial Sloan Kettering Cancer Center who will build on his previous research using patient-specific rectal cancer organoids to grow human-specific rectal cancer models in mice as a platform for developing personalized treatments.

  • Robin B. Mendelson of Memorial Sloan Kettering Cancer Center who will describe the gut microbiome of patients under age of 50, comparing them to the microbiomes of older people with colorectal cancer and the microbiomes of younger healthy people.

  • Joshua Meyer of Fox Chase Cancer Center who will describe the genetic and genomic features of colorectal cancer patients young and old, and thoroughly characterize the biology of young-onset colorectal in patients under 50 years old.

  • Rosa Maria Munoz Xicola of the Yale School of Medicine will provide essential knowledge on how the APC-negative subset of colorectal cancers develop, which is crucial in the development of effective early detection tests and treatments. Xicola will also investigate whether the APC-negative subset disproportionately affects African Americans and young people.

The Colorectal Cancer Alliance is now accepting applications for its prevention research grants. The application deadline is 11:59 p.m., Monday, March 18, 2019.


Funding opportunities for FY19–DOD Breast Cancer Research Program

The FY19 Defense Appropriation provides $130 million to the Department of Defense Breast Cancer Research Program to support innovative, high-impact research with clinical relevance that will accelerate progress to end breast cancer for Service members, Veterans, and the general public.

FY19 BCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the website.

Applications submitted to the FY19 BCRP must address one or more of the following overarching challenges:

  • Prevent breast cancer (primary prevention)

  • Identify determinants of breast cancer initiation, risk, or susceptibility

  • Distinguish deadly from non-deadly breast cancers

  • Conquer the problems of overdiagnosis and overtreatment

  • Identify what drives breast cancer growth; determine how to stop it

  • Identify why some breast cancers become metastatic

  • Determine why/how breast cancer cells lie dormant for years and then re-emerge; determine how to prevent lethal recurrence

  • Revolutionize treatment regimens by replacing them with ones that are more effective, less toxic, and impact survival

  • Eliminate the mortality associated with metastatic breast cancer

Copyright (c) 2019 The Cancer Letter Inc.